Save the Box
The Save the Box campaign is an Australian initiative from the Australia New Zealand Gynaecological Oncology Group (ANZGOG) to raise much needed funds and awareness for research into gynaecological cancers.
Gynaecological cancers are cancers of the female reproductive system. There are seven types: ovarian, uterine (often called endometrial or womb), vulvar, vaginal, cervical and two rare pregnancy-related cancers. Gynaecological cancers are the third most commonly diagnosed cancers in women, with more than 18,469 women living with a gynae cancer and a further 6073 women expected to be diagnosed by the end of this year. These are the unacceptable facts about gynaecological cancer.
Endometrial (uterine) cancer is one of the five most commonly diagnosed cancers in women. Uterine cancer incidence has increased by 22% over the 26 years from 1982 to 2008, due mainly to the obesity epidemic.
Only four in 10 women diagnosed with ovarian cancer will survive five years after diagnosis. This compares to nine in 10 women surviving breast cancer in the same period.
While there is a routine screening test for cervical cancer, there are no routine screening tests for the other types of gynaecological cancers. This means they can go undetected until symptoms present.
It's time to take action, break the silence and raise funds for research to help our mothers, sisters, friends, daughters and granddaughters face better odds in their futures.
The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is the peak national gynaecological cancer research organisation. ANZGOG are recognised as a world leader in clinical trials research.
ANZGOG's mission is to improve life for women with ovarian and other gynaecological cancers through research, cooperative clinical trials, information and awareness. ANZGOG’s research has changed clinical practice both locally and globally.
Established more than 15 years ago, ANZGOG have led more than 20 clinical trials with volunteer participation from more than 3,000 women. ANZGOG's membership is made up of more than 850 medical, nursing and health specialists working across 50 hospitals in Australia and New Zealand.
ANZGOG directly fund research through two innovative programs:
The Ovarian Cancer Alliance for Signal-Seeking Research (OASIS) initiative – created to improve treatments for ovarian cancer by targeting molecular subtypes. OASIS studies are smart, nimble, cost-effective Phase 2 studies identifying the most effective treatments for the subtypes of ovarian cancer. Some of the subtypes are incredibly rare and without OASIS are unlikely to be specifically addressed by typical research programs.
Stimulating and funding new research ideas – our Fund for New Research grant ensures new ideas have the seed funding needed to get off the ground.
ANZGOG's research has changed gynaecological cancer treatments for the better, identified new ways to support women’s quality of life while living with cancer, and improved gynaecological cancer survival. For more information please go to www.anzgog.org.au